CHS INC - CHSINC 7.1 PERP (CHSCN) Fundamental Analysis & Valuation

NASDAQ:CHSCN • US12542R5063

Current stock price

25.02 USD
+0.02 (+0.08%)
Last:

This CHSCN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CHSCN Profitability Analysis

1.1 Basic Checks

  • CHSCN had a positive operating cash flow in the past year.
  • In the past 5 years CHSCN has always been profitable.
  • In the past 5 years CHSCN always reported a positive cash flow from operatings.
CHSCN Yearly Net Income VS EBIT VS OCF VS FCFCHSCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • CHSCN's Return On Assets of 2.96% is in line compared to the rest of the industry. CHSCN outperforms 59.77% of its industry peers.
  • With a decent Return On Equity value of 5.48%, CHSCN is doing good in the industry, outperforming 60.92% of the companies in the same industry.
  • CHSCN has a Return On Invested Capital (0.37%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for CHSCN is below the industry average of 7.14%.
Industry RankSector Rank
ROA 2.96%
ROE 5.48%
ROIC 0.37%
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
CHSCN Yearly ROA, ROE, ROICCHSCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CHSCN has a Profit Margin (1.75%) which is comparable to the rest of the industry.
  • CHSCN's Profit Margin has improved in the last couple of years.
  • CHSCN has a Operating Margin (0.21%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CHSCN has declined.
  • Looking at the Gross Margin, with a value of 3.21%, CHSCN is doing worse than 81.61% of the companies in the same industry.
  • CHSCN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.21%
PM (TTM) 1.75%
GM 3.21%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
CHSCN Yearly Profit, Operating, Gross MarginsCHSCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

3

2. CHSCN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCN is destroying value.
  • Compared to 1 year ago, CHSCN has a worse debt to assets ratio.
CHSCN Yearly Shares OutstandingCHSCN Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCN Yearly Total Debt VS Total AssetsCHSCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.10 indicates that CHSCN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CHSCN (2.10) is comparable to the rest of the industry.
  • CHSCN has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • CHSCN's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. CHSCN outperforms 63.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 2.1
ROIC/WACC0.07
WACC5.46%
CHSCN Yearly LT Debt VS Equity VS FCFCHSCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • CHSCN has a Current Ratio of 1.42. This is a normal value and indicates that CHSCN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.42, CHSCN is in line with its industry, outperforming 44.83% of the companies in the same industry.
  • CHSCN has a Quick Ratio of 1.42. This is a bad value and indicates that CHSCN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CHSCN (0.80) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.8
CHSCN Yearly Current Assets VS Current LiabilitesCHSCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1

3. CHSCN Growth Analysis

3.1 Past

  • The Revenue has decreased by -5.74% in the past year.
  • Measured over the past years, CHSCN shows a small growth in Revenue. The Revenue has been growing by 4.54% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCN Yearly Revenue VS EstimatesCHSCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

1

4. CHSCN Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCN Price Earnings VS Forward Price EarningsCHSCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 96.55% of the companies in the same industry are more expensive than CHSCN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.35
CHSCN Per share dataCHSCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. CHSCN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.10%, CHSCN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.47, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 88.51% of the companies listed in the same industry.
  • CHSCN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 7.1%

5.2 History

  • CHSCN has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CHSCN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
CHSCN Yearly Dividends per shareCHSCN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CHSCN pays out 27.52% of its income as dividend. This is a sustainable payout ratio.
DP27.52%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCN Yearly Income VS Free CF VS DividendCHSCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B
CHSCN Dividend Payout.CHSCN Dividend Payout, showing the Payout Ratio.CHSCN Dividend Payout.PayoutRetained Earnings

CHSCN Fundamentals: All Metrics, Ratios and Statistics

CHS INC - CHSINC 7.1 PERP

NASDAQ:CHSCN (3/23/2026, 4:30:00 PM)

25.02

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-06
Earnings (Next)03-31
Inst Owners10.86%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap307.00M
Revenue(TTM)35.03B
Net Income(TTM)613.61M
Analysts0
Price TargetN/A
Short Float %0.67%
Short Ratio4.43
Dividend
Industry RankSector Rank
Dividend Yield 7.1%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP27.52%
Div Incr Years0
Div Non Decr Years10
Ex-Date03-17
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.52
P/B 0.03
P/tB 0.03
EV/EBITDA 2.35
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.86
FCFYN/A
OCF(TTM)48.25
OCFY192.83%
SpS2855.14
BVpS913.07
TBVpS913.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.96%
ROE 5.48%
ROCE 0.54%
ROIC 0.37%
ROICexc 0.38%
ROICexgc 0.38%
OM 0.21%
PM (TTM) 1.75%
GM 3.21%
FCFM N/A
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score4
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 4.81
Cap/Depr 96.64%
Cap/Sales 1.86%
Interest Coverage 250
Cash Conversion 79.1%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 0.8
Altman-Z 2.1
F-Score4
WACC5.46%
ROIC/WACC0.07
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.46%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.15%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%

CHS INC - CHSINC 7.1 PERP / CHSCN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSCN.


What is the valuation status for CHSCN stock?

ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7.1 PERP (CHSCN). This can be considered as Overvalued.


What is the profitability of CHSCN stock?

CHS INC - CHSINC 7.1 PERP (CHSCN) has a profitability rating of 4 / 10.


Can you provide the financial health for CHSCN stock?

The financial health rating of CHS INC - CHSINC 7.1 PERP (CHSCN) is 3 / 10.